Deconstructing Antiobesity Compound Action: Requirement of Serotonin 5-HT(2B) Receptors for Dexfenfluramine Anorectic Effects.: Anorectic compounds and 5-HTreceptors

Abstract : The now-banned anorectic molecule, dexfenfluramine, promotes serotonin release through a serotonin transporter-dependent mechanism, and it has been widely prescribed for the treatment of obesity. Previous studies have identified that 5-HT(2B) receptors have important roles in dexfenfluramine side effects, that is, pulmonary hypertension, plasma serotonin level regulation, and valvulopathy. We thus investigated a putative contribution of 5-HT(2B) receptors in dexfenfluramine-dependent feeding behavior in mice. Interestingly, the hypophagic response to dexfenfluramine (3-10 mg/kg) observed in wild-type mice (1-4 h) was eliminated in mice lacking 5-HT(2B) receptors (5-HT(2B)(-/-)). These findings were further validated by the lack of hypophagic response to dexfenfluramine in wild-type mice treated with RS127445, a highly selective and potent antagonist (pKi=8.22±0.24). Using microdialysis, we observed that in 5-HT(2B)(-/-) awake mice, the dexfenfluramine-induced hypothalamic peak of serotonin release (1 h) was strongly reduced (fourfold) compared with wild type. Moreover, using hypothalamic synaptosomes, we established the serotonergic neuron autonomous properties of this effect: a strong serotonin release was observed upon dexfenfluramine stimulation of synaptosome preparation from wild type but not from mice lacking active 5-HT(2B) receptors. These findings strongly suggest that activation of presynaptic 5-HT(2B) receptors is a limiting step in the serotonin transporter dependant-releasing effect of dexfenfluramine, whereas other serotonin receptors act downstream with respect to feeding behavior.
Type de document :
Article dans une revue
Neuropsychopharmacology, Nature Publishing Group, 2011, 36 (2), pp.423-33. 〈10.1038/npp.2010.173〉
Liste complète des métadonnées

Littérature citée [46 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00549170
Contributeur : Luc Maroteaux <>
Soumis le : mardi 21 décembre 2010 - 14:17:14
Dernière modification le : mercredi 21 mars 2018 - 18:57:30
Document(s) archivé(s) le : vendredi 2 décembre 2016 - 14:41:11

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

Citation

Sophie Banas, Stéphane Doly, Katia Boutourlinsky, Silvina Diaz, Arnauld Belmer, et al.. Deconstructing Antiobesity Compound Action: Requirement of Serotonin 5-HT(2B) Receptors for Dexfenfluramine Anorectic Effects.: Anorectic compounds and 5-HTreceptors. Neuropsychopharmacology, Nature Publishing Group, 2011, 36 (2), pp.423-33. 〈10.1038/npp.2010.173〉. 〈inserm-00549170〉

Partager

Métriques

Consultations de la notice

123